Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;24(1):39–44. doi: 10.1002/clc.4960240107

Influence of age on left atrial appendage function in patients with nonvalvular atrial fibrillation

Arzu Ilercil 1,, Jyothi Kondapaneni 1, Aung Hla 1, Jamshid Shirani 1
PMCID: PMC6654982  PMID: 11195605

Abstract

Background: Age is an independent risk factor for thromboembolism in nonvalvular atrial fibrillation (NVAF). An association between low left atrial appendage (LAA) Doppler velocities and thromboembolic risk in NVAF has been reported.

Methods: Forty‐two consecutive patients (age 69 ± 2 years [range 42–92], 24 [57%] men) with NVAF underwent transthoracic and transesophageal echocardiography. The following were compared in 22 patients younger and 20 older than 70 years: left ventricular (LV) diameter, mass and ejection fraction, left atrial (LA) diameter and volume, LAA area and volume, LAA peak emptying (PE) and peak filling (PF) velocities, presence and severity of spontaneous echo contrast (SEC) and mitral regurgitation (MR).

Results: Left atrial diameter (4.6 ± 0.1 vs. 4.5 ± 0.2 cm), LA volume (105 ± 10 vs. 92 ± 8 ml), LAA area (6.8 ± 0.6 vs. 5.2 ± 0.8 cm), and LAA volume (5.6 ± 0.9 vs. 3.9 ± 1.0 ml) were similar (p>0.05) in both groups. Older patients had lower LAA PE (26 ± 2 vs. 34 ± 3 cm/s, p = 0.02) and PF (32 ± 2 vs. 41 ± 4 cm/s, p = 0.04) velocities, lower LV mass (175 ± 13 vs. 234 ± 21 gm, p = 0.02), higher relative wall thickness (0.52 ± 0.02 vs. 0.43 ± 0.03, p = 0.02), smaller LV diastolic diameter (4.3 ± 0.1 vs. 5.2 ± 0.2 cm, p <0.001), and higher LV ejection fraction (62 ± 2 vs. 55 ± 2%, p = 0.025). Frequency and severity of SEC and MR were similar in both groups. Multivariate analysis identified older age as the only significant predictor of reduced LAA velocities.

Conclusion: Compared with younger patients, older patients with NVAF have lower LAA velocities despite higher LV ejection fraction, smaller LV size, and similar LA and LAA volumes. These findings may explain the higher thromboembolic rates in older patients with NVAF.

Keywords: atrial fibrillation, echocardiography, age, left atrial appendage, embolism

Full Text

The Full Text of this article is available as a PDF (541.1 KB).

References

  • 1. Ezekowitz MD, Levine JA: Preventing stroke in patients with atrial fibrillation. J Am Med Assoc 1999; 281: 1830–1835 [DOI] [PubMed] [Google Scholar]
  • 2. Wolf PA, Dawber TR, Thomas HE, Thomas HE Jr, Kannel WB: Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study. Neurology 1978; 28: 973–977 [DOI] [PubMed] [Google Scholar]
  • 3. Petersen P, Boysen G, Godtfredsen J, Boysen G, Andersen ED, Andersen B: Placebo‐controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK study. Lancet 1989; 1: 175–179 [DOI] [PubMed] [Google Scholar]
  • 4. Stroke Prevention in Atrial Fibrillation Investigators : Preliminary report of the stroke prevention in atrial fibrillation study. N Engl J Med 1990; 322: 863–868 [DOI] [PubMed] [Google Scholar]
  • 5. Atrial Fibrillation Investigators : Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994; 154: 1449–1457 [PubMed] [Google Scholar]
  • 6. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke. The Framingham Study. Stroke 1991; 22: 983–988 [DOI] [PubMed] [Google Scholar]
  • 7. Stroke Prevention in Atrial Fibrillation Investigators : Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke prevention in atrial fibrillation II study. Lancet 1994; 343: 687–691 [PubMed] [Google Scholar]
  • 8. Stroke Prevention in Atrial Fibrillation Investigators : Adjusteddose warfarin versus low‐intensity, fixed‐dose warfarin plus aspirin for high‐risk patients with atrial fibrillation: Stroke prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996; 348: 633–638 [PubMed] [Google Scholar]
  • 9. Mitush R, Garbe M, Schmücker G, Schwabe K, Stierle U, Sheikhzadeh A: Relation of left atrial appendage function to the duration and reversibility of nonvalvular atrial fibrillation. Am J Cardiol 1995; 75: 944–947 [DOI] [PubMed] [Google Scholar]
  • 10. Panagiotopoulos K, Toumanidis S, Saridakis N, Vemmos K, Moulopoulos S: Left atrial and left atrial appendage functional abnormalities in patients with cardioembolic stroke in sinus rhythm and idiopathic atrial fibrillation. J Am Soc Echocardiogr 1998; 11: 711–719 [DOI] [PubMed] [Google Scholar]
  • 11. Mugge A, Kühn H, Nikutta P, Grote J, Lopez AG, Daniel WG: Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: Identification of a subgroup of patients at increased embolic risk. J Am Coll Cardiol 1994; 23: 599–607 [DOI] [PubMed] [Google Scholar]
  • 12. Shively BK, Gelgand EA, Crawford MH: Regional left atrial stasis during atrial fibrillation and flutter: Determinants and relation to stroke. J Am Coll Cardiol 1996; 27: 1722–1729 [DOI] [PubMed] [Google Scholar]
  • 13. Verhorst PMJ, Kamp O, Visser CA, Verheugt FWA: Left atrial appendage flow velocity assessment using transesophageal echocardiography in nonrheumatic atrial fibrillation and symtemic embolism. Am J Cardiol 1993; 71: 192–196 [DOI] [PubMed] [Google Scholar]
  • 14. Pollick C, Taylor D: Assessment of left atrial appendage function by transesophageal echocardiography: Implications for the development of thrombus. Circulation 1991; 84: 223–231 [DOI] [PubMed] [Google Scholar]
  • 15. Fatkin D, Kelly RP, Fenely MP: Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994; 23: 961–969 [DOI] [PubMed] [Google Scholar]
  • 16. Aurigemma GP, Gaasch WH, Villegas B, Meyer TE: Noninvasive assessment of left ventricular mass, chamber volume, and contractile function. Curr Probl Cardiol 1995; 20: 361–440 [PubMed] [Google Scholar]
  • 17. Weyman AE: Left ventricular inflow tract II: The left atrium, pulmonary veins, and coronary sinus In Principles and Practice of Echocardiography, (Ed. Weyman AE.), p. 477 Philadelphia: Lea & Febiger, 1994. [Google Scholar]
  • 18. Stollberger C, Chnupa P, Kronik G, Brainin M, Finsterer J, Schneider B, Slany J: Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. Ann Intern Med 1998; 128: 630–638 [DOI] [PubMed] [Google Scholar]
  • 19. Seward JB, Khandheria BK, Oh JK, Freeman WK, Tajik AJ: Critical appraisal of transesophageal echocardiography: Limitations, pitfalls, and complications. J Am Soc Echocardiogr 1992; 5: 288–305 [DOI] [PubMed] [Google Scholar]
  • 20. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458 [DOI] [PubMed] [Google Scholar]
  • 21. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550–1558 [DOI] [PubMed] [Google Scholar]
  • 22. Lewis JF, Duo LC, Nelson JG, Limacher MC, Quinones MA: Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: Clinical validation of two new methods using the apical window. Circulation 1984; 70; 425–431 [DOI] [PubMed] [Google Scholar]
  • 23. Yao SS, Meisner JS, Strom JA, Shirani J: Left atrial appendage volume can be estimated by transesophageal echocardiography using a modified area‐length formula derived from necropsy data (abstr). J Am Soc Echocardiogr 1997; 10: 420 [Google Scholar]
  • 24. Laupacis A, Albers G, Dalen J, Dunn M, Feinberg W, Jacobson A: Antithrombotic therapy in atrial fibrillation. Chest 1995; 108: 352s–359s [DOI] [PubMed] [Google Scholar]
  • 25. Stroke Prevention in Atrial Fibrillation Investigators : Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 1992; 116: 1–5 [DOI] [PubMed] [Google Scholar]
  • 26. Stroke Prevention in Atrial Fibrillation Investigators : Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med 1992; 116: 6–12 [DOI] [PubMed] [Google Scholar]
  • 27. Atrial Fibrillation Investigators : Echocardiographic predictors of stroke in patients with atrial fibrillation. Arch Intent Med 1998; 158: 1316–1320 [DOI] [PubMed] [Google Scholar]
  • 28. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography : Transesophageal echocardiographic correlates of thromboembolism in high risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998; 128: 639–647 [DOI] [PubMed] [Google Scholar]
  • 29. Black IW, Hopkins AP, Lee LCL, Walsh WF, Jacobson BM: Left atrial spontaneous echo contrast: A clinical and echocardiographic analysis. J Am Coll Cardiol 1991; 18: 398–404 [DOI] [PubMed] [Google Scholar]
  • 30. Tabata T, Oki T, Fukuda N, Iuchi A, Manabe K, Kageji Y, Sasaki M, Yamada H, Ito S: Influence of aging on left atrial appendage flow velocity patterns in normal subjects. J Am Soc Echocardiogr 1996; 9: 274–280 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES